Abstract
Recent clinical experiences and clinical trials have demonstrated the safety, tolerability, and efficacy of non-invasive vagus nerve stimulation (nVNS; gammaCore®) for the acute and prophylactic treatment of migraine. nVNS has a favorable adverse event profile, making it an attractive option for sensitive patient populations. We explored the safety, tolerability, and efficacy of nVNS as acute migraine treatment in adolescents. A group of adolescent patients suffering from migraine without aura were trained to use gammaCore to manage their migraine attacks. 46.8% of the treated migraine attacks (22/47) were considered successfully treated and did not require any rescue medication. No device-related adverse events were recorded. This preliminary study suggests that nVNS may represent a safe, well-tolerated, and effective for acute migraine treatment in adolescents.
References
Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24(suppl 1):9–160
Wober-Bingol C (2013) Epidemiology of migraine and headache in children an adolescents. Curr Pain Headache Rep 17(6):341
Hershey AD (2010) Current approaches to the diagnosis and management of paediatric migraine. Lancet Neurol 9(2):190–2014
Magis D, Schoenen J (2012) Advances and challenges in neurostimulation for headaches. Lancet Neurol 11(8):708–719. doi:10.1016/S1474-4422(12)70139-
Connor DE Jr, Nixon M, Nanda A, Guthikonda B (2012) Vagal nerve stimulation for the treatment of medically refractory epilepsy: a review of the current literature. Neurosurg Focus 32(3):E12. doi:10.3171/2011.12.FOCUS11328
Grimm S, Bajbouj M (2010) Efficacy of vagus nerve stimulation in the treatment of depression. Expert Rev Neurother 10(1):87–92. doi:10.1586/ern.09.138
Mauskop A (2005) Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches. Cephalalgia 25(2):82–86. doi:10.1111/j.1468-2982.2005.00611.x
Multon S, Schoenen J (2005) Pain control by vagus nerve stimulation: from animal to man...And back. Acta Neurol Belg 105(2):62–67
ElectroCore® receives FDA approval for chronic migraine study. http://www.electrocoremedical.com/electrocore-receives-fda-approval-for-chronic-migraine-study. Published June 14, 2012. Accessed April 17, 2015
Jürgens TP, Leone M (2013) Pearls and pitfalls: neurostimulation in headache. Cephalalgia 33(8):512–525. doi:10.1177/0333102413483933
Goadsby PJ, Grosberg B, Mauskop A, Cady R, Simmons KA (2014) Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study. Cephalalgia 34(12):986–993. doi:10.1177/0333102414524494
Nesbitt AD, Marin JC, Tompkins E, Ruttledge MH, Goadsby PJ (2015) Initial use of a novel noninvasive vagus nerve stimulator for cluster headache treatment. Neurology 84(12):1249–1253. doi:10.1212/WNL.0000000000001394
Silberstein SD, Da Silva AN, Calhoun AH et al. (2014) Non-invasive vagus nerve stimulation for chronic migraine prevention in a prospective, randomized, sham-controlled pilot study (the EVENT Study): report from the double-blind phase. Late-breaking poster presented at: 56th Annual Scientific Meeting of the American Headache Society; Los Angeles, California; June 26–29, 2014. LBP19
Gaul C, Diener HC, Solbach K et al (2014) gammaCore® use for prevention and acute treatment of chronic cluster headache: findings from the randomized phase of the PREVA study. Ann Neurol 76(suppl 8):S15
Barbanti P, Grazzi L, Egeo G, Padovan AM, Liebler E, Bussone G (2015) Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study. The Journal of Headache and Pain 16:61
Grazzi L, Egeo G, Calhoun AH, McClure CK, Liebler E, Barbanti P (2016) Non-invasive vagus nerve stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study. J Headache and Pain 17(1):91
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Grazzi, L., Egeo, G., Liebler, E. et al. Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study. Neurol Sci 38 (Suppl 1), 197–199 (2017). https://doi.org/10.1007/s10072-017-2942-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-017-2942-5